Both in Biotechnology
Kalaris Therapeutics vs ImageneBio
Over the past year KLRS returned −57.9% and IMA returned −52.3%; their daily moves had a correlation of 0.10.
KLRS −57.9% IMA −52.3%Growth of $1, one year, split-adjusted
| Metric | KLRS | IMA |
|---|---|---|
| Price | $2.10 | $4.01 |
| Market cap | $50.0M | $45.5M |
| Today | +2.44% | −0.25% |
| 1 month | −21.1% | −12.8% |
| 6 months | −58.5% | −34.0% |
| Year to date | −75.1% | −41.9% |
| 1 year | −57.9% | −52.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $93.5M | $136.2M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 37.2% |
| Short % of float | 5.4% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).